Xeris Biopharma Holdings, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
XERS Nasdaq 2834 www.xerispharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Xeris Biopharma Holdings, Inc.

Xeris Hosts Webinar Detailing Its Comprehensive Development Program for XP-8121, an Investigational, Once-Weekly Subcutaneous Levothyroxine for Hypothyroidism - Sep 9th, 2026 6:30 am
Xeris Announces Details for XP-8121 Program Overview Webinar - Aug 26th, 2026 5:30 am
Why Xeris Biopharma Holdings (XERS) Is Up 8.4% After Tightening 2026 Revenue Guidance And Advancing XP-8121 - Aug 15th, 2026 12:11 am
Xeris Biopharma Holdings (XERS) Posts Record Q2 Revenue, Is It Still A Bargain? - Aug 14th, 2026 1:10 pm
Xeris (XERS) Q2 2026 Earnings Call Transcript - Aug 13th, 2026 10:15 am
Xeris Biopharma Q2 Earnings Call Highlights - Aug 7th, 2026 2:04 pm
Xeris Biopharma Holdings Inc (XERS) (Q2 2026) Earnings Call Highlights: Record Revenue and ... - Aug 6th, 2026 5:13 pm
Compared to Estimates, Xeris Biopharma (XERS) Q2 Earnings: A Look at Key Metrics - Aug 6th, 2026 7:30 am
Xeris Biopharma Reports Second Quarter 2026 Financial Results - Aug 6th, 2026 5:00 am
Xeris Biopharma to Report Second Quarter 2026 Financial Results on August 6, 2026 - Jul 23rd, 2026 5:30 am
Xeris Biopharma (XERS) Moves 6.8% Higher: Will This Strength Last? - Jul 8th, 2026 8:37 am
CORRECTING and REPLACING Xeris Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Jul 2nd, 2026 8:40 pm
Is Xeris Biopharma Holdings, Inc. (XERS) Stock Positioned for Long-Term Growth With Extended Keveyis Exclusivity? - Jun 30th, 2026 7:08 am
Xeris Announces Updates to Its Board of Directors - Jun 30th, 2026 5:00 am
Xeris Biopharma Announces Notice of Allowance From U.S. Patent and Trademark Office for New Patent Covering KEVEYIS® - Jun 11th, 2026 2:39 pm
Xeris Biopharma Announces Private Exchange of Convertible Notes - Jun 11th, 2026 5:00 am
Shareholders Will Be Pleased With The Quality of Xeris Biopharma Holdings' (NASDAQ:XERS) Earnings - May 15th, 2026 5:49 am
Results: Xeris Biopharma Holdings, Inc. Confounded Analyst Expectations With A Surprise Profit - May 9th, 2026 8:19 am